Abstract
Surgery is the primary treatment for renal cancer. However, with inadequate renal function or in patients with solitary kidneys, it may not be a safe function preserving option. When surgery is not desirable other ablative therapies such as radiofrequency ablation or SBRT have been used. Conventional external beam radiation has limited value and can be toxic to the remaining kidney or the surrounding organs. Highly conformal stereotactic body radiotherapy (SBRT) can be an effective and safe nonsurgical option for selected renal cancers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.
Butler BP, Novick AC, Miller DP, Campbell SA, Licht MR. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology. 1995;45(1):34–40; discussion 40–41.
Barbalias GA, Liatsikos EN, Tsintavis A, Nikiforidis G. Adenocarcinoma of the kidney: nephron-sparing surgical approach vs. radical nephrectomy. J Surg Oncol. 1999;72(3):156–61.
Leibovich BC, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol. 2004;171(3):1066–70.
Adkins KL, Chang SS, Cookson MS, Smith JA. Partial nephrectomy safely preserves renal function in patients with a solitary kidney. J Urol. 2003;169(1):79–81.
Lane BR, Gill IS. 5-Year outcomes of laparoscopic partial nephrectomy. J Urol. 2007;177(1):70–4; discussion 74.
Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7(9):735–40.
Lane BR, Novick AC, Babineau D, Fergany AF, Kaouk JH, Gill IS. Comparison of laparoscopic and open partial nephrectomy for tumor in a solitary kidney. J Urol. 2008;179(3):847–51; discussion 852.
Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer. 2008;113(10):2671–80.
Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj GV. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol. 2008;179(1):75–9; discussion 79–80.
Juusela H, Malmio K, Alfthan O, Oravisto KJ. Preoperative irradiation in the treatment of renal adenocarcinoma. Scand J Urol Nephrol. 1977;11(3):277–81.
Kjaer M, Iversen P, Hvidt V, Bruun E, Skaarup P, Bech Hansen J, et al. A randomized trial of postoperative radiotherapy versus observation in stage II and III renal adenocarcinoma. A study by the Copenhagen Renal Cancer Study Group. Scand J Urol Nephrol. 1987;21(4):285–9.
Wersall PJ, Blomgren H, Lax I, Kalkner K-M, Linder C, Lundell G, et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol. 2005;77(1):88–95.
Finney R. The value of radiotherapy in the treatment of hypernephroma—a clinical trial. Br J Urol. 1973;45(3):258–69.
Svedman C, Sandström P, Pisa P, Blomgren H, Lax I, Kälkner K-M, et al. A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma. Acta Oncol. 2006;45(7):870–5.
Ponsky LE, Crownover RL, Rosen MJ, Rodebaugh RF, Castilla EA, Brainard J, et al. Initial evaluation of Cyberknife technology for extracorporeal renal tissue ablation. Urology. 2003;61(3):498–501.
Beitler JJ, Makara D, Silverman P, Lederman G. Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma. Am J Clin Oncol. 2004;27(6):646–8.
Ponsky LE, Mahadevan A, Gill IS, Djemil T, Novick AC. Renal radiosurgery: initial clinical experience with histological evaluation. Surg Innov. 2007;14(4):265–9.
Hong Y. Cyberknife radiosurgical ablation of primary renal tumors. J Endourol. 2008;22(S1):A1–310.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag London
About this chapter
Cite this chapter
Kaplan, I.D., Mahadevan, A., Wagner, A.A. (2015). Stereotactic Body Radiotherapy for Renal Cancer. In: Gaya, A., Mahadevan, A. (eds) Stereotactic Body Radiotherapy. Springer, London. https://doi.org/10.1007/978-0-85729-597-2_12
Download citation
DOI: https://doi.org/10.1007/978-0-85729-597-2_12
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-596-5
Online ISBN: 978-0-85729-597-2
eBook Packages: MedicineMedicine (R0)